The Capital Ideas podcast now has a new monthly edition hosted by Capital Group CEO Mike Gitlin.

Investment professionals reveal their best mentors, how they find their next great idea, and a few funny stories.

Subscribe wherever you get your podcast. American Funds Distributors, Inc.

Hey, What's News listeners. It's Sunday, December 8th.

I'm Luke Vargas for the Wall Street Journal, and this is What's News Sunday, the show where we tackle the big questions about the biggest stories in the news by reaching out to our colleagues across the newsroom to help explain what's happening in our world.

In the waning weeks of his campaign, Donald Trump embraced Robert F. Kennedy Jr.'s war on junk food

in a bid to win over his supporters. And that was just the beginning, as he later took on Kennedy's

crusade against processed foods, environmental toxins, and the broader American health care system.

With Kennedy and others once dismissed for their unorthodox medical

and scientific views just weeks away from taking on leading policy roles in Washington,

how did we get here? What changes are Trump and his allies promising? What hurdles will

they face in implementing them? And how is the private sector likely to respond? All that and more

coming up. Let's get into it.

Reporter Liz Esley-White is based in Washington, D.C., where her coverage focuses on the FDA, and

Jonathan Rockoff is the journal's health business editor. Liz, I want to start with you. You had a

recent piece titled How Science

Lost America's Trust and Surrendered Health Policy to Skeptics. We have left a link to that great

article in our show notes. And I imagine the complete answer to the question, how do we get here,

is one that we do not have enough time to really get into fully. But you seem to chalk this up

to two things, a combination of residual

pandemic frustration and basically a longstanding distrust of the medical establishment and the

food industry. Am I understanding you correctly? Yeah, that's right. Robert F. Kennedy,

...